Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 199

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 199
---
 Living Homeopathy’s Class A Ordinary Shares
may not develop. Future sales of substantial amounts of Living Homeopathy’s Class A Ordinary Shares in the public market after
Living Homeopathy’s initial public offering, or the possibility of these sales occurring, could cause the prevailing market price
for Living Homeopathy’s Class A Ordinary Shares to fall or impair Living Homeopathy’s ability to raise equity capital in
the future. Upon completion of this offering, the Company will have 10,250,000 Class A Ordinary Shares issued and outstanding. All of
the Class A Ordinary Shares sold in this offering will be freely transferable by persons other than Living Homeopathy’s “affiliates”
without restriction or further registration under the Securities Act.

Lock-Up Agreements

The Company has agreed to enter into a customary
lock-up agreement for a period of three (3) months from the date of the offering, subject to certain exceptions, among others, with respect
to any shares of capital stock of the Company or any securities convertible or exchangeable for shares of capital stock of the Company,
without the prior written consent of the representative of the Underwriters. See “Underwriting” beginning on page
123 of this prospectus for more information.

Furthermore, each of Living Homeopathy’s
directors, executive officers, and principal shareholders of 5% and more of the Class A Ordinary Shares as of the effective date of this
registration statement of the Company’s outstanding share capital has also agreed to enter into a similar lock-up agreement for
a period of six (6) months from the date of the offering, subject to certain exceptions, with respect to any shares of capital stock
of the Company or any securities convertible or exchangeable for shares of capital stock of the Company, without the prior written consent
of the representative of the Underwriters. See “Underwriting” beginning on page 123 of this prospectus for more information.

The Company is not aware of any plans by any significant shareholders to dispose of significant numbers of the Company’s Ordinary Shares. However, one or more existing shareholders or owners of securities convertible or exchangeable into or exercisable for the Company’s Ordinary Shares may dispose of significant numbers of the Company’s Ordinary Shares in the future. The Company cannot predict what effect, if any, future sales of the Company’s Ordinary Shares, or the availability of Company’s Ordinary Shares for future sale, will have on the trading price of Living Homeopathy’s Class A Ordinary Shares from time to time. Sales of substantial amounts of Living Homeopathy’s